US Patent Issued to DANA-FARBER CANCER INSTITUTE, BETH ISRAEL DEACONESS MEDICAL CENTER, YEDA RESEARCH AND DEVELOPMENT on Sept. 8 for "Inhibitors of the peptidyl-prolyl cis/trans isomerase (PIN1), combinations and uses thereof" (American, Israeli Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,132, issued on Sept. 8, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston), BETH ISRAEL DEACONESS MEDICAL CENTER INC. (Boston) and YEDA RESEARCH AND DEVELOPMENT Co. LTD. (Rehovot, Israel).

"Inhibitors of the peptidyl-prolyl cis/trans isomerase (PIN1), combinations and uses thereof" was invented by Shizhong Ke (Boston), Gerburg Wulf (Boston), Xiao Zhen Zhou (Newton, Mass.), Nir London (Rehovot, Israel), Wenyi Wei (Boston), Kun Ping Lu (Newton, Mass.), Nathanael S. Gray (Stanford, Calif.) and Behnam Nabet (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of treating diseases or disorders mediated by dysregulated CDK4...